Paraneoplastic Syndromes Medication

1. Lancaster E. Paraneoplastic disorders. Continuum (Minneap Minn). 2015 Apr. 21 (2 Neuro-oncology):452-75. [QxMD MEDLINE Link].

2. Gultekin SH. Recent developments in paraneoplastic disorders of the nervous system. Surg Pathol Clin. 2015 Mar. 8 (1):89-99. [QxMD MEDLINE Link].

3. Bilynsky BT, Dzhus MB, Litvinyak RI. The conceptual and clinical problems of paraneoplastic syndrome in oncology and internal medicine. Exp Oncol. 2015 Jun. 37 (2):82-8. [QxMD MEDLINE Link].

4. Hobbs CB, Miller AL. Review of endocrine syndromes associated with tumours of non-endocrine origin. J Clin Pathol. 1966 Mar. 19(2):119-27. [QxMD MEDLINE Link].

5. Gilligan M, McGuigan C, McKeon A. Paraneoplastic Neurologic Disorders. Curr Neurol Neurosci Rep. 2023 Mar. 23 (3):67-82. [QxMD MEDLINE Link].

6. Hashiba T, Saitoh Y, Asanuma N, et al. Reduction of a pancreatic tumor after total removal of an ACTH secreting pituitary tumor: differential diagnosis of Cushing's syndrome. Endocr J. 2006 Apr. 53(2):203-8. [QxMD MEDLINE Link].

7. Höftberger R, Rosenfeld MR, Dalmau J. Update on neurological paraneoplastic syndromes. Curr Opin Oncol. 2015 Sep 1. [QxMD MEDLINE Link].

8. Auche M. Des nevrites peripheriques chez les cancereux. Rev Med. 1890. 10:785-807.

9. Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol. 2004 Nov. 56(5):715-9. [QxMD MEDLINE Link].

10. Brain R, Norris FH eds. The remote effects of cancer on the nervous system. New York: Grune & Stratton; 1965.

11. Minisola S, Fukumoto S, Xia W, Corsi A, Colangelo L, Scillitani A, et al. Tumor-induced Osteomalacia: A Comprehensive Review. Endocr Rev. 2023 Mar 4. 44 (2):323-353. [QxMD MEDLINE Link].

12. Rubenstein M, Duvic M. Cutaneous manifestations of Hodgkin's disease. Int J Dermatol. 2006 Mar. 45(3):251-6. [QxMD MEDLINE Link].

13. Kaltsas G, Dimitriadis GK, Androulakis II, Grossman A, De Groot LJ, Chrousos G, et al. Paraneoplastic Syndromes related to Neuroendorine Tumours. 2017. [QxMD MEDLINE Link]. [Full Text].

14. Lipka AF, Boldingh MI, van Zwet EW, Schreurs MWJ, Kuks JBM, Tallaksen CM, et al. Long-term follow-up, quality of life, and survival of patients with Lambert-Eaton myasthenic syndrome. Neurology. 2020 Feb 4. 94 (5):e511-e520. [QxMD MEDLINE Link]. [Full Text].

15. Leger S, Picard D, Ingen-Housz-Oro S, Arnault JP, Aubin F, et al. Prognostic factors of paraneoplastic pemphigus. Arch Dermatol. 2012 Oct. 148(10):1165-72. [QxMD MEDLINE Link].

16. Kawasoe T, Yamamoto Y, Okumura Y, et al. A case report of paraneoplastic neurological syndrome associated with occult breast cancer. Breast Cancer. 2006. 13(2):202-4. [QxMD MEDLINE Link].

17. Noorani A, Sadiq Z, Minakaran N, et al. Paraneoplastic cerebellar degeneration as a presentation of breast cancer - a case report and review of the literature. Int Semin Surg Oncol. 2008 Apr 21. 5:8. [QxMD MEDLINE Link].

18. Hagler KT, Lynch JW Jr. Paraneoplastic manifestations of lymphoma. Clin Lymphoma. 2004 Jun. 5(1):29-36. [QxMD MEDLINE Link].

19. Wang A, Zeidan A, Brunet C. Rheumatologic manifestations of hematologic neoplasms. Curr Rheumatol Rev. 2016 Aug 15. 31(9):1854-7. [QxMD MEDLINE Link].

20. Gandhi L, Johnson BE. Paraneoplastic syndromes associated with small cell lung cancer. J Natl Compr Canc Netw. 2006 Jul. 4(6):631-8. [QxMD MEDLINE Link].

21. Ge F, Li ZJ, Cao ZL. Thymoma associated with severe diarrhoea and anaemia. Chin Med J (Engl). 2006 Mar 20. 119(6):526-8. [QxMD MEDLINE Link].

22. Batsis JA, Morgenthaler TI. Trousseau syndrome and the unknown cancer: use of positron emission tomographic imaging in a patient with a paraneoplastic syndrome. Mayo Clin Proc. 2005 Apr. 80(4):537-40. [QxMD MEDLINE Link].

23. Zalatnai A, Perjési E, Galambos E. Much More than Trousseau Syndrome. The Broad Spectrum of the Pancreatic Paraneoplastic Syndromes. Pathol Oncol Res. 2018 Jan. 24 (1):1-10. [QxMD MEDLINE Link].

24. Rabhi M, Ennibi K, Harket A, et al. Acquired ichthyosis disclosing non-Hodgkin's malignant lymphoma. Intern Med. 2007. 46(7):397-9. [QxMD MEDLINE Link].

25. Silva JA, Mesquita Kde C, Igreja AC, Lucas IC, Freitas AF, Oliveira SM, et al. Paraneoplastic cutaneous manifestations: concepts and updates. An Bras Dermatol. 2013 Jan-Feb. 88 (1):9-22. [QxMD MEDLINE Link]. [Full Text].

26. Molina Garrido MJ, Guillen Ponce C, Macia Escalante S, et al. Cushing's paraneoplastic syndrome as first manifestation of an adenocarcinoma of unknown origin. Clin Transl Oncol. 2006 Aug. 8(8):621-3. [QxMD MEDLINE Link].

27. Meinardi JR, van den Berg G, Wolffenbuttel BH, et al. Cyclical Cushing's syndrome due to an atypical thymic carcinoid. Neth J Med. 2006 Jan. 64(1):23-7. [QxMD MEDLINE Link].

28. Takagi J, Otake K, Morishita M, et al. Multiple endocrine neoplasia type I and Cushing's syndrome due to an aggressive ACTH producing thymic carcinoid. Intern Med. 2006. 45(2):81-6. [QxMD MEDLINE Link].

29. Soomro Z, Youssef M, Yust-Katz S, Jalali A, Patel AJ, Mandel J. Paraneoplastic syndromes in small cell lung cancer. J Thorac Dis. 2020 Oct. 12 (10):6253-6263. [QxMD MEDLINE Link]. [Full Text].

30. Mygland A, Vincent A, Newsom-Davis J, et al. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia. Arch Neurol. 2000 Apr. 57(4):527-31. [QxMD MEDLINE Link].

31. Riedel RF, Burfeind WR Jr. Thymoma: benign appearance, malignant potential. Oncologist. 2006 Sep. 11(8):887-94. [QxMD MEDLINE Link].

32. Tormoehlen LM, Pascuzzi RM. Thymoma, myasthenia gravis, and other paraneoplastic syndromes. Hematol Oncol Clin North Am. 2008 Jun. 22(3):509-26. [QxMD MEDLINE Link].

33. Fisher PG, Singer HS. Paraneoplastic opsoclonus. Neurology. 1995 Jul. 45(7):1421-2. [QxMD MEDLINE Link].

34. Anderson NE. Limbic encephalitis and anti-neuronal antibodies. Pathology. 1989 Apr. 21(2):152-3. [QxMD MEDLINE Link].

35. Serafini A, Lukas RV, VanHaerents S, Warnke P, Tao JX, Rose S, et al. Paraneoplastic epilepsy. Epilepsy Behav. 2016 Aug. 61:51-8. [QxMD MEDLINE Link].

36. Benke T, Wagner M, Pallua AK, et al. Long-term cognitive and MRI findings in a patient with paraneoplastic limbic encephalitis. J Neurooncol. 2003 Jan. 66(1-2):217-24. [QxMD MEDLINE Link].

37. Cleverly K, Gambadauro P, Navaratnarajah R. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis: have you checked the ovaries?. Acta Obstet Gynecol Scand. 2014 Jul. 93(7):712-5. [QxMD MEDLINE Link].

38. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011 Jan. 10 (1):63-74. [QxMD MEDLINE Link]. [Full Text].

39. Jeraiby M, Depincé-Berger A, Bossy V, Antoine JC, Paul S. A case of anti-NMDA receptor encephalitis in a woman with a NMDA-R(+) small cell lung carcinoma (SCLC). Clin Immunol. 2016 May. 166-167:96-9. [QxMD MEDLINE Link].

40. Rees J. Paraneoplastic neurological disorders. J Neurol Neurosurg Psychiatry. 2014 Aug. 85(8):e3. [QxMD MEDLINE Link].

41. Ypma PF, Wijermans PW, Koppen H, et al. Paraneoplastic cerebellar degeneration preceding the diagnosis of Hodgkin's lymphoma. Neth J Med. 2006 Jul-Aug. 64(7):243-7. [QxMD MEDLINE Link].

42. Waterhouse DM, Natale RB, Cody RL. Breast cancer and paraneoplastic cerebellar degeneration. Cancer. 1991 Oct 15. 68(8):1835-41. [QxMD MEDLINE Link].

43. Greenlee JE, Clawson SA, Hill KE, Dechet CB, Carlson NG. Antineuronal autoantibodies in paraneoplastic cerebellar degeneration associated with adenocarcinoma of the prostate. J Neurol Sci. 2010 Jan 18. [QxMD MEDLINE Link].

44. Scheinfeld NS. Ulcerative paraneoplastic dermatomyositis secondary to metastatic breast cancer. Skinmed. 2006 Mar-Apr. 5(2):94-6. [QxMD MEDLINE Link].

45. Fardet L, Dupuy A, Gain M, Kettaneh A, Chérin P, Bachelez H, et al. Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis. Medicine (Baltimore). 2009 Mar. 88(2):91-7. [QxMD MEDLINE Link].

46. Marko PB, Miljkovic J, Zemljic TG. Necrolytic migratory erythema associated with hyperglucagonemia and neuroendocrine hepatic tumors. Acta Dermatovenerol Alp Panonica Adriat. 2005 Dec. 14(4):161-4, 166. [QxMD MEDLINE Link].

47. Savvari P, Peitsidis P, Alevizaki M, Dimopoulos MA, Antsaklis A, Papadimitriou CA. Paraneoplastic humorally mediated hypercalcemia induced by parathyroid hormone-related protein in gynecologic malignancies: a systematic review. Onkologie. 2009 Sep. 32(8-9):517-23. [QxMD MEDLINE Link].

48. Fujita T, Fukuda K, Nishi H, et al. Paraneoplastic hypercalcemia with adenosquamous carcinoma of the colon. Int J Clin Oncol. 2005 Apr. 10(2):144-7. [QxMD MEDLINE Link].

49. Darnell RB. Paraneoplastic neurologic disorders: windows into neuronal function and tumor immunity. Arch Neurol. 2004 Jan. 61(1):30-2. [QxMD MEDLINE Link].

50. Li Z, Han D, Chen T, Zhang L, Wang Y, Liu Y, et al. Paraneoplastic stiff-person syndrome with lung cancer: a case report and literature review. Am J Transl Res. 2023. 15 (1):330-335. [QxMD MEDLINE Link]. [Full Text].

51. Ubriani R, Grossman ME. Facial papules as a marker of internal malignancy. Med Clin North Am. 2009 Nov. 93(6):1305-31. [QxMD MEDLINE Link].

52. Graus F, Vogrig A, Muñiz-Castrillo S, Antoine JG, Desestret V, Dubey D, et al. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. Neurol Neuroimmunol Neuroinflamm. 2021 Jul. 8 (4):[QxMD MEDLINE Link]. [Full Text].

53. Iwata T, Inoue K, Mizuguchi S, et al. Thymectomy for paraneoplastic stiff-person syndrome associated with invasive thymoma. J Thorac Cardiovasc Surg. 2006 Jul. 132(1):196-7. [QxMD MEDLINE Link].

54. Vatankulu B, Yilmaz Aksoy S, Asa S, Sager S, Sayman HB, et al. Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes. Rev Esp Med Nucl Imagen Mol. 2015 Aug 7. [QxMD MEDLINE Link].

55. Kristensen SB, Hess S, Petersen H, Høilund-Carlsen PF. Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients. Eur J Nucl Med Mol Imaging. 2015 Jul 21. [QxMD MEDLINE Link].

56. Buchwald B, Ahangari R, Weishaupt A, et al. Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins. Muscle Nerve. 2005 Apr. 31(4):487-94. [QxMD MEDLINE Link].

57. Koski CL, Patterson JV. Intravenous immunoglobulin use for neurologic diseases. J Infus Nurs. 2006 May-Jun. 29(3 Suppl):S21-8. [QxMD MEDLINE Link].

58. Williamson BT, Foltz L, Leitch HA. Autoimmune Syndromes Presenting as a Paraneoplastic Manifestation of Myelodysplastic Syndromes: Clinical Features, Course, Treatment and Outcome. Hematol Rep. 2016 May 10. 8 (2):6480. [QxMD MEDLINE Link]. [Full Text].

59. Barnadas M, Roe E, Brunet S, et al. Therapy of paraneoplastic pemphigus with Rituximab: a case report and review of literature. J Eur Acad Dermatol Venereol. 2006 Jan. 20(1):69-74. [QxMD MEDLINE Link].

60. Kaplan I, Hodak E, Ackerman L, et al. Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations. Oral Oncol. 2004 Jul. 40(6):553-62. [QxMD MEDLINE Link].

61. Lane JE, Woody C, Davis LS, et al. Paraneoplastic autoimmune multiorgan syndrome (paraneoplastic pemphigus) in a child: case report and review of the literature. Pediatrics. 2004 Oct. 114(4):e513-6. [QxMD MEDLINE Link]. [Full Text].

62. Wade MS, Black MM. Paraneoplastic pemphigus: a brief update. Australas J Dermatol. 2005 Feb. 46(1):1-8; quiz 9-10. [QxMD MEDLINE Link].

63. Li H, Yan W, Mao Q, et al. Role of adrenalectomy in ectopic ACTH syndrome. Endocr J. 2005 Dec. 52(6):721-6. [QxMD MEDLINE Link].

Luigi Santacroce, MD Assistant Professor, Medical School, State University at Bari, Italy

Disclosure: Nothing to disclose.

Laura Diomede University of Bari School of Medicine, Italy

Disclosure: Nothing to disclose.

Lodovico Balducci, MD Professor, Oncology Fellowship Director, Department of Internal Medicine, Division of Adult Oncology, H Lee Moffitt Cancer Center and Research Institute, University of South Florida Morsani College of Medicine

Lodovico Balducci, MD is a member of the following medical societies: American Association for the Advancement of Science, American Association for Cancer Research, American College of Physicians, American Geriatrics Society, American Society of Hematology, New York Academy of Sciences, American Society of Clinical Oncology, Southern Society for Clinical Investigation, International Society for Experimental Hematology, American Federation for Clinical Research, American Society of Breast Disease

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Benjamin Movsas, MD

Benjamin Movsas, MD is a member of the following medical societies: American College of Radiology, American Radium Society, American Society for Radiation Oncology

Disclosure: Nothing to disclose.

Wafik S El-Deiry, MD, PhD Rose Dunlap Professor of Medicine, Chief, Division of Hematology and Oncology, Penn State Hershey Medical Center

Wafik S El-Deiry, MD, PhD is a member of the following medical societies: American Association for Cancer Research, American Society for Clinical Investigation, American Society of Gene and Cell Therapy

Disclosure: Nothing to disclose.

Silvia Gagliardi, MD Consulting Staff, Department of Surgery, Medical Center Vita, Italy

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article